検索結果 16 件

María Pilar Barretina-Ginesta, María Quindós, Jesús Damián Alarcón, Carmen Esteban, Lydia Gaba, César Gómez, José Alejandro Pérez Fidalgo, Ignacio Romero, Ana Santaballa, María Jesús Rubio-Pérez Clinical and Translational Oncology 24 (4), 625-634, 2022-03-21

<jats:title>Abstract</jats:title><jats:p>Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, the first in developed countries [Sung et al. in CA Cancer J Clin …

DOI PDF Web Site 被引用文献1件

Kathleen N. Moore, Michael Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna Mäenpää, Lyndsay Willmott, Nicoletta Colombo, Jessica Thomes-Pepin, Michalis Liontos, Michael A. Gold, Yolanda Garcia, Sudarshan K. Sharma, Christopher J. Darus, Carol Aghajanian, Aikou Okamoto, Xiaohua Wu, Rustem Safin, Fan Wu, Luciana Molinero, Vidya Maiya, Victor K. Khor, Yvonne G. Lin, Sandro Pignata Journal of Clinical Oncology 39 (17), 1842-1855, 2021-06-10

<jats:sec><jats:title>PURPOSE</jats:title><jats:p> To evaluate the addition of the humanized monoclonal antiprogrammed death ligand-1 (PD-L1) antibody, atezolizumab, to platinum-based chemotherapy …

DOI Web Site 被引用文献6件

Antonio Gonzalez Martin, Ursula A. Matulonis, Jacob Korach, Mansoor Raza Mirza, Kathleen N. Moore, Divya Gupta, Stanislav Lechpammer, Bradley J. Monk Journal of Clinical Oncology 39 (15_suppl), 5518-5518, 2021-05-20

<jats:p> 5518 </jats:p><jats:p> Background: Niraparib has been approved for the maintenance treatment of patients with advanced ovarian, fallopian tube, or primary peritoneal cancer after front-line …

DOI 被引用文献1件

Céline Callens, Dominique Vaur, Isabelle Soubeyran, Etienne Rouleau, Pierre-Alexandre Just, Erell Guillerm, Lisa Golmard, Nicolas Goardon, Nicolas Sevenet, Odile Cabaret, Philipp Harter, Antonio Gonzalez-Martin, Keiichi Fujiwara, Sabrina Chiara Cecere, Nicoletta Colombo, Christian Marth, Ignace Vergote, Johanna Maenpaa, Eric Pujade-Lauraine, Isabelle Ray-Coquard JNCI: Journal of the National Cancer Institute 2020-12-29

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>PAOLA1 is a phase III study assessing olaparib maintenance …

DOI PDF 被引用文献1件

Krishnansu S. Tewari, Michael W. Sill, Bradley J. Monk, Richard T. Penson, David H. Moore, Heather A. Lankes, Lois M. Ramondetta, Lisa M. Landrum, Leslie M. Randall, Ana Oaknin, Mario M. Leitao, Eric L. Eisenhauer, Paul DiSilvestro, Linda Van Le, Michael L. Pearl, James J. Burke, Ritu Salani, Debra L. Richardson, Helen E. Michael, David W. Kindelberger, Michael J. Birrer Molecular Cancer Therapeutics 19 (11), 2363-2370, 2020-11-01

<jats:title>Abstract</jats:title> <jats:p>To isolate circulating tumor cells (CTC) from women with advanced cervical cancer and estimate the impact of CTCs and treatment on overall …

DOI PDF 被引用文献1件

Domenica Lorusso, Jean-Pierre Lotz, Philipp Harter, Claire Cropet, Maria Jesus Rubio Pérez, Christian Schauer, Takashi Matsumoto, Ignace Vergote, Nicoletta Colombo, Trine Jakobi Noettrup, Hugues Pierre Bourgeois, Andreas Schnelzer, Sandro Pignata, Yolanda Garcia, Magali Provansal, Lars Christian Hanker, Dominique Berton, Dirk Bauerschlag, Florence Joly, Isabelle Laure Ray-Coquard Journal of Clinical Oncology 38 (15_suppl), 6039-6039, 2020-05-20

<jats:p> 6039 </jats:p><jats:p> Background: In PAOLA-1/ENGOT-ov25 (NCT02477644), adding the PARP inhibitor olaparib to maintenance bev after first-line platinum-based chemotherapy plus bev led to a …

DOI 被引用文献1件

Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, Kris Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley F. Haggerty, Maria J. Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk New England Journal of Medicine 381 (25), 2391-2402, 2019-12-19

DOI Web Site 被引用文献26件

Josep M. del Campo, Ursula A. Matulonis, Susanne Malander, Diane Provencher, Sven Mahner, Philippe Follana, Justin Waters, Jonathan S. Berek, Kathrine Woie, Amit M. Oza, Ulrich Canzler, Marta Gil-Martin, Anne Lesoin, Bradley J. Monk, Bente Lund, Lucy Gilbert, Robert M. Wenham, Benedict Benigno, Sujata Arora, Sebastien J. Hazard, Mansoor R. Mirza Journal of Clinical Oncology 37 (32), 2968-2973, 2019-11-10

<jats:sec><jats:title>PURPOSE</jats:title><jats:p> In the ENGOT-OV16/NOVA trial (ClinicalTrials.gov identifier: NCT01847274 ), maintenance therapy with niraparib, a poly(ADP-ribose) polymerase …

DOI Web Site 被引用文献2件

Juan Francisco Grau, Lorena Farinas-Madrid, Ana Oaknin International Journal of Gynecologic Cancer 30 (1), 139-143, 2019-10-23

...GEICO is the lead group on behalf of ENGOT....

DOI Web Site 被引用文献1件

Susanna Leskela, Ignacio Romero, Eva Cristobal, Belén Pérez-Mies, Juan M. Rosa-Rosa, Ana Gutierrez-Pecharroman, Almudena Santón, Belén O. Gonzalez, Raquel López-Reig, David Hardisson, Francisco Vera-Sempere, Carmen Illueca, Begoña Vieites, José A. López-Guerrero, José Palacios, Andrés Poveda American Journal of Surgical Pathology 44 (2), 149-161, 2019-09-06

<jats:p>The frequency and prognostic significance of the histologic type in early-stage ovarian cancer (OC) is not as well established as in advanced stages. In addition, histologic typing based …

DOI Web Site 被引用文献2件

Yolanda Garcia Garcia, Ana de Juan Ferré, Cesar Mendiola, Maria-Pilar Barretina-Ginesta, Lydia Gaba Garcia, Ana Santaballa Bertrán, Isabel Bover Barcelo, Marta Gil-Martin, Aranzazu Manzano, Maria Jesús Rubio Pérez, Margarita Romeo Marin, Cristina Arqueros Núñez, Elena García-Martínez, Antonio Gonzalez Martin International Journal of Gynecologic Cancer 29 (6), 1050-1056, 2019-07

<jats:sec><jats:title>Background</jats:title><jats:p>Bevacizumab is an approved treatment after primary debulking surgery for ovarian cancer. However, there is limited information on bevacizumab …

DOI Web Site 被引用文献1件

Yolanda Garcia Garcia, Ana De Juan, Cesar Mendiola, Maria Pilar Barretina-Ginesta, Aleix Prat, Ana Santaballa, Isabel Bover, Marta Gil-Martin, Aránzazu Manzano, M Jesus Rubio, Margarita Romeo, Cristina Arqueros, Elena Garcia Martinez, Antonio Gonzalez Martin Journal of Clinical Oncology 35 (15_suppl), 5508-5508, 2017-05-20

<jats:p> 5508 </jats:p><jats:p> Background: First line carboplatin(C)-paclitaxel(P) and Bev has proved to be an active combination after primary debulking surgery and improve overall survival in …

DOI Web Site 被引用文献1件

Andreas Du Bois, Ignace Vergote, Gwenael Ferron, Alexander Reuss, Werner Meier, Stefano Greggi, Pernille Tina Jensen, Frédéric Selle, Frederic Guyon, Christophe Pomel, Fabrice Lecuru, Rongyu Zang, Elisabeth Avall-Lundqvist, Jae Weon Kim, Jordi Ponce, Francesco Raspagliesi, Sadaf Ghaem-Maghami, Alexander Reinthaller, Philipp Harter, Jalid Sehouli Journal of Clinical Oncology 35 (15_suppl), 5501-5501, 2017-05-20

<jats:p> 5501 </jats:p><jats:p> Background: The role of secondary cytoreductive surgery in recurrent ovarian cancer (OC) has not been defined by level-1 evidence. Methods: Pts with OC and 1st …

DOI Web Site 被引用文献1件

Andres M. Poveda, Frédéric Selle, Felix Hilpert, Alexander Reuss, Antonella Savarese, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Nana Scotto, Lada Mitchell, Eric Pujade-Lauraine Journal of Clinical Oncology 33 (32), 3836-3838, 2015-11-10

DOI Web Site 被引用文献7件

Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace B. Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David T. Bollag, Isabelle Ray-Coquard Journal of Clinical Oncology 30 (18_suppl), LBA5002-LBA5002, 2012-06-20

<jats:p> LBA5002^ </jats:p><jats:p> Background: In three phase III trials in OC (2 front line, 1 PT-sensitive recurrent), BEV + CT → BEV significantly improved progression-free survival (PFS) vs CT …

DOI Web Site 被引用文献1件

A.J. González-Martín, E. Calvo, I. Bover, M.J. Rubio, A. Arcusa, A. Casado, B. Ojeda, C. Balañá, E. Martínez, A. Herrero, B. Pardo, E. Adrover, J. Rifá, M.J. Godes, A. Moyano, A. Cervantes Annals of Oncology 16 (5), 749-755, 2005-05

DOI PDF Web Site ほか1件 被引用文献1件